Abstract
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Michael Koch is first author on ‘ Dose-dependent effects of Nrf2 on the epidermis in chronic skin inflammation’, published in DMM. Michael conducted the research described in this article while a PhD candidate and research scientist in Professor Sabine Werner's lab at ETH Zürich, Zürich, Switzerland. His research interests include determining how dysregulation of complex networks on a molecular level leads to disease on an organ level, and how we can target those dysregulations to develop novel therapeutic approaches.